The National Institute of Allergy and Infectious Diseases (NIAID)-funded researchers who developed a genetically modified mosquito-killing fungus, a weapon made from spider toxin, that destroys blood-sucking enemies from the inside and helps save people from disease and death.
Mosquitoes that landed on surfaces coated with the antimalarial compound atovaquone were completely blocked from developing Plasmodium falciparum (P. falciparum), the parasite that causes malaria, according to new research led by Harvard T.H. Chan School of Public Health.
One of the world’s oldest and deadliest diseases — remains a critically important public health and biomedical research challenge. Despite remarkable advances in reducing malaria incidence and deaths since 2000, recent progress has become stagnant and has even reversed in some regions.
The Government of Malawi has launched the world’s first malaria vaccine in a landmark pilot programme aimed at combating one of the world’s leading killers.
Malaria control campaign launched in Democratic Republic of the Congo to save lives and aid Ebola response
A spike in malaria cases is threatening the health of people in parts of the eastern Democratic Republic of the Congo (DRC) where health workers are also battling an Ebola outbreak.
WHO and partners launch new country-led response to put stalled malaria control efforts back on track
A child dies of malaria every 2 minutes. 61% of all malaria deaths globally in 2017 were among children under 5. No one should die from a disease that can be easily prevented and diagnosed, and that is entirely curable with available treatments.